| Clinical endpoint |
Urine high-risk HPV
|
Cervical high-risk HPV
|
Urine high-risk HPV
|
Cervical high-risk HPV
|
|
%
|
95% CI
|
%
|
95% CI
|
%
|
95% CI
|
%
|
95% CI
|
| Cervical HPV (n=51) |
51.0 |
37.0 - 65.0 |
N/A |
|
96.2 |
92.0 - 99.0 |
N/A |
|
| ASCUS/LSIL/HSIL (n=38) |
47.4 |
31.0 - 64.2 |
57.9 |
40.8 - 73.7 |
92.0 |
86.9 - 95.5 |
83.5 |
77.2 - 88.7 |